Immune-mediated disease pathogenesis in respiratory syncytial virus infection

Immunopharmacology

Volumn 48, Issue 3, 2000, Pages 237-247

  Graham, Barney S ^a   Johnson, Teresa R ^a   Stokes Peebles, R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway hyperresponsiveness; Asthma; Eosinophils; Eotaxin; G glycoprotein; IL 13; IL 5; Interferon ; Interleukin (IL) 4; Mucus; T lymphocytes; Vaccines

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOPATHOGENESIS; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

ANIMALS; ASTHMA; CYTOKINES; GLYCOPROTEINS; HUMANS; LUNG; PULMONARY EOSINOPHILIA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 0034713711     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)00233-2     Document Type: Conference Paper

References (55)

1. Ahvan, W.H., Openshaw, P.J.M., 1993. Distinct patterns of T-and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 11, 431-437.
2. Alwan, W.U., Kozlowska, W.J., Openshaw, P.J.M., 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179,81-89.
3. Aung, S., Tang, Y.W., Graham, D.S., 1999. IL-4 inhibits induction of cytotoxic T lymphocyte activity in mice infected with recombinant vaccinia virus expressing respiratory syncytial viras M2 protein. J. Virol. 73, 8944-8949.
4. Aung, S., Graham, B.S., 2000. Differential regulation of perforinand FasL-mediated cytotoxicity by IL-4. J. Immunol. 164, 3487-3493.
5. Belshe, R.B., Van Voris, L.P., Mufson, M.A., 1982. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J. Infect. Dis. 145, 311-319.
6. Bembridge, G.P., Lopez, J.A., Bustos, R., Mêlera, J.A., Cook, R., Mason, H., Taylor, G., 1999. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge. J. Virol. 73, 100S6-10094.
7. Brandt, C., Power, U.F., Plotnicky-Gilquin, H., Huss, T., Nquyen, T., Lambert, P.H., Binz, H., Siegrist, C.A., 1997. Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2NA. J. Infect. Dis. 176, 884-891.
8. Chin, J., Magoffin, R.L., Shearer, L.A., Schieble, J.H., Lennette, E.H., 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pédiatrie population. Am. J. Epidemiol. 89, 449-463.
9. Connors, M., Kulkarni, A.B., Firestone, C.Y., Holmes, K.L., Morse, H.C., Sotnikov, A.V., Murphy, B.R., 1992. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol. 66, 7444-7451.
10. Falsey, A.R., Cunningham, C.K., Barker, W.H., Kouides, R.W., Yuen, J.B., Menegus, M., Weiner, L.B., Bonville, C.A., Betts, R.F., 1995. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J. Infect. Dis. 172, 389-394.
11. Feldman, S.A., Hendry, R.M., Beeler, J.A., 1999. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J. Virol. 73, 6610-6617.
12. Garofalo, R., Kimpen, J.L.L., Welliver, R.C., Ogra, P.L., 1992. Eosinophil degranulation in the respiratory tact during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120, 28-32.
13. Glezen, P., Denny, F.W., 1973. Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 288, 498-505.
14. Gorman, J.J., Ferguson, B.L., Spekman, D., Mills, J., 1997. Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrixassisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sei. 6, 1308-1315.
15. Graham, B.S., Bunton, L.A., Rowland, J., Wright, P.P., Karzon, D.T., 1991a. Respiratory syncytial virus infection in anti-mutreated mice. J. Virol. 65, 4936-4942.
16. Graham, B.S., Bunton, L.A., Wright, P.P., Karzon, D.T., 1991b. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88, 1026-1033.
17. Graham, B.S., Henderson, O.S., Tang, Y.W., Lu, X., Neuzil, K.M., Colley, D.G., 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151, 2032-2040.
18. Respiratory Syncytial Virus Immune Globulin Study Group, Groothuis, J.R., Simoes, E.A.F., Levin, M.J., Hall, C.B., Long, C.E., Rodriquez, W.J., Arrobio, J., Meissner, H.C., Fulton, D.R., Welliver, R.C., Tristram, D.A., Siber, G.A., Prince, G.A., Van Raden, M., Hemming, V.G., 1993. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N. Engl. J. Med. 329, 1524-1530.
19. Hancock, G.E., Speelman, D.J., Heers, K., Borteil, E., Smith, J., Cosco, C, 1996. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J. Virol. 70, 7783-7791.
20. Hendricks, D.A., Baradaran, K., Mclntosh, K., Patterson, J.L., 1987. Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J. Gen. Virol. 68, 1705-1714.
21. Hertz, M.I., Englund, J.A., Snover, D., Bitterman, P.B., McGIave, P.B., 1989. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine 68, 269281.
22. Hussell, T., Openshaw, P.J., 1998. Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J. Gen. Virol. 79, 2593-2601.
23. Hussell, T., Baldwin, C.J., O'Garra, A., Openshaw, P.J.M., 1997. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27, 3341-3349.
24. IMpact-RSV Study Group, 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531-537.
25. Johnson, P.R., Spriggs, M.K., Olmsted, R.A., Collins, P.L., 1987. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sei. U. S. A. 84, 5625-5629.
26. Johnson, T.R., Johnson, J.E., Roberts, S.R., Wertz, G.W., Parker, R.A., Graham, B.S., 1998. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J. Virol. 72, 2871-2880.
27. Johnson, T.R., Graham, B.S., 1999. Secreted respiratory syncytial virus (RSV) G protein induces IL-5, IL-13, and eosinophilia by an IL-4-independent mechanism. J. Virol. 73, 8485-8495.
28. Karron, R.A., Buonaguria, D.A., Georgiu, A.F., Whitehead, S.S., Adamus, J.E., Clements Mann, M.L., Harris, D.O., Randolph, V.B., Udem, S.A., Murphy, B.R., Sidhu, M.S., 1997. Respira-tory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sei. U. S. A. 94, 13961-13966.
29. Kim, H.W., Canchola, J.G., Brandt, C.D., Pyles, G., Chanock, R.M., Jensen, K., Parrott, R.H., 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenie inactivated vaccine. Am. J. Epidemiol. 89, 422-434.
30. Lambert, D.M., 1988. Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins. Virology 164, 458-466.
31. Levine, S., Klaiber-Franco, R., Paradiso, P.R., 1987. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68, 2521-2524.
32. Li, X., Sambhara, S., Li, C.X., Ewasyshyn, M., Parrington, M., Caterini, J., James, O., Gates, G., Du, R.P., Klein, M, 1998. Protection against respiratory syncytial virus infection by DNA immunization. J. Exp. Med. 188, 681-688.
33. Murphy, B.R., Graham, B.S., Prince, G.A., Walsh, E.E., Chanock, R.M., Karzon, D.T., Wright, P.P., 1986. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J. Clin. Microbiol. 23,1009-1014.
34. Murray, M., Webb, M.S., O'Callaghan, C, Swarbrick, A.S., Milner, A.D., 1992. Respiratory status and allergy after bronchiolitis. Arch. Dis. Child. 67, 482-487.
35. Olmsted, R.A., Elango, N., Prince, G.A., Murphy, B.R., Johnson, P.R., Moss, B., Chanock, R.M., Collins, P.L., 1986. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc. Natl. Acad. Sei. U. S. A. 83, 7462-7466.
36. Openshaw, P.J.M., Clarke, S.L., Record, P.M., 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4, 493-500.
37. Palomo, C., Garcia-Barreno, B., Penas, C., Melero, J.A., 1991. The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity. J. Gen. Virol. 72, 669-675.
38. Peebles, R.S. Jr., Sheller, J.R., Johnson, J.E., Mitchell, D.B., Graham, B.S., 1999. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice. J. Med. Virol. 57, 186-192.
39. Roberts, S.R., Lichtenstein, D., Ball, L.A., Wertz, G.W., 1994. The membrane-associated and secreted forms of the respiratory syncylial virus attachment glycoprotein G are synthesized from alternative initiation codons. J. Virol. 68, 4538-4546.
40. Shay, O.K., Holman, R.C., Newman, R.D., Liu, L.L., Stout, J.W., Anderson, L.J., 1999. Bronchiolitis-associated hospitalizations among US children, 1980-1999. JAMA, J. Am. Med. Assoc. 282, 1440-1446.
41. Sigurs, N., Bjarnason, R., Sigurbergsson, F., Kjellman, B., Bjorksten, B., 1995. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 95, 500-505.
42. Simard, C., Nadon, F., Seguin, C., Trudel, M., 1995. Evidence that the amino acid region 124-203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection. Antiviral Res. 28, 303-315.
43. Simard, C., Nadon, F., Seguin, C., Thien, N.N., Binz, H., Basso, J., Laliberte, J.F., Trudel, M., 1997. Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: the role of cysteinyl residues in protection. Vaccine 15, 423-432.
44. Srikiatkachorn, A., Braciale, T.J., 1997. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186, 421432.
45. Srikiatkhachorn, A., Chang, V., Braciale, T.J., 1999. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompalibility complex independent. J. Virol. 73, 6590-6597.
46. Sparer, T.E., Matthews, S., Hussell, T., Rae, A.J., Garcia-Barreno, B., Melero, J.A., Openshaw, P.J.M., 1998. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J. Exp. Med. 187, 1921-1926.
47. Stott, E.J., Ball, L.A., Young, K.K., Furze, J., Wertz, G.W., 1986. Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge. J. Virol. 60, 607-613.
48. Tang, Y.W., Graham, B.S., 1994. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94, 1953-1958.
49. Taylor, G., Stott, E.J., Bew, M., Fernie, B.F., Cote, P.J., Collins, A.P., Hughes, M., Jebbett, J., 1984. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52, 137-142.
50. Tebbey, P.W., Hagen, M., Hancock, G.E., 1998. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J. Exp. Med. 188, 1967-1972.
51. Tripp, R.A., Moore, D., Jones, L., Sullender, V., Winter, J., Andersen, L.J., 1999. Respiratory syncytial virus G and/or SH protein alters Thl cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J. Virol. 73, 7099-7107.
52. Volovitz, B., Welliver, R.C., De Castro, G., Krystofik, D.A., Ogra, P.L., 1988. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr. Res. 24, 504-507.
53. Walsh, E.E., Schlesinger, J.J., Brandriss, M.W., 1984. Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. J. Gen. Virol. 65, 761-767.
54. Waris, M.E., Tsou, C., Erdman, D.D., Zaki, S.R., Anderson, L.J., 1996. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70, 2852-2860. Welliver, R.C., Wong, D.T., Sun, M., Middleton, E. Jr., Vaughan, R.S., Ogra, P.L., 1981. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N. Engl. J. Med. 305, 841-846.
55. Wertz, G.W., Collins, P.L., Huang, Y., Gruber, C., Lcvine, S., Ball, L.A., 1985. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc. Natl. Acad. Sei. U. S. A. 82, 4075-4079.